INDIVIDUAL RESEARCHER
Harold A. Singer
, Ph.D.
Professor & Director
e-mail: singerh@mail.amc.edu
Education
1982 - Ph.D. from Dept. of Pharmacology, University of VirginiaCurrent Research
Research Interests: 1. intracellular signaling by protein kinases 2. structure/function of CaM kinase II isozymes 3. regulation of vascular smooth muscle cell contraction, migration and growth The principal objective of this laboratory is to define intracellular signaling pathways that mediate contractile and growth stimulus induced responses in vascular smooth muscle (VSM). This knowledge provides a basis for; a) understanding pathology underlying pervasive vascular diseases including hypertension, atherosclerosis, and injury-induced blood vessel occlusion resulting from VSM cell hyperplasia, and b) rational targeting of therapeutic agents aimed at controlling these disorders. Research is focused on two multifunctional protein kinase families, protein kinase C (PKC)and Ca2+/calmodulin-dependent protein kinase II (CaM kinase II). Our previous work implicated PKC as a regulator of VSM contractile activity, functioning in parallel to the established regulatory system involving myosin light chain kinase, which phosphorylates and activates the contractile protein myosin. Currently, we are exploring the functional significance of a physical interaction between a specific form of PKC (PKCdelta) and intracellular components of cell attachment (focal adhesion) complexes with respect to the control of VSM cell motility, gene expression and proliferative responses stimulated by injury and stretch. Ca2+ is an essential intracellular messenger in virtually all cells and participates in the control of numerous cellular functions, including muscle contraction. Our second major area of interest is to establish the role of CaM kinase II as a mediator of these intracellular Ca2+ signals. This laboratory has been instrumental in discovering new forms of CaM kinase II that are variably expressed in all cells. We have used this knowledge to develop molecular, immunological, and pharmacological approaches that we are applying to studies of CaM kinase II function in VSM. Our current goals are: 1) to define how CaM kinase II subunit/holoenzyme structure and autophosphorylation affects targeting of the kinase to specific cellular locations, 2) to determine the role of CaM kinase II as an intermediate in the activation of mitogen activated protein kinase (MAP kinase), another multifunctional protein kinase which is important in controlling patterns of gene expression and cell growth, and 3) to determine how CaM kinase II regulates contractile function in arterial smooth muscle.References
- Potier M*, Motiani RK*, Gonzalez JC*, Abdullaev IF, Bisaillon JM, Singer HA, Trebak M. Evidence for STIM1- and Orai1(CRACM1)-dependent Store-Operated Calcium Influx through ICRAC in Vascular Smooth Muscle cells: Role in Proliferation and Migration. FASEB J. Aug;23(8):2425-37. Epub 2009 Apr 13.
- House SJ, Singer HA: CaMKII(delta) isoform regulation of neointima formation after vascular injury. Arterioscler Thromb Vasc Biol 28:441-447, 2008.
- House SJ, Potier M, Bisaillon J, Singer HA, Trebak M. The non-excitable smooth muscle: Calcium signaling and phenotypic switching during vascular disease. Pflugers Arch. 456(5):769-85, 2008.
- Ginnan R, Guikema BJ, Halligan KE, Singer HA, Jourd'heuil D. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic Biol Med. 44(7):1232-45, 2008
- Mercure MZ, Ginnan R, Singer HA. CaM kinase II delta2-dependent regulation of vascular smooth muscle cell polarization and migration. Am J Physiol Cell Physiol. 294(6):C1465-75, 2008.